home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences

Search

 
  Cambridge Healthtech Institute's Proteins to Profits  
  January 28, 2003

Biotechnology

 
     
  Cambridge Healthtech Institute, Hilton Munchen Park, Am Tucherpark 7, D-80538, Munich, Germany
April 24-25, 2003


Today the pharmaceutical discovery lab faces the challenges of:

1) reducing drug development time
2) speeding up identification of new and validated drug targets
3) developing high-quality information early in the discovery process

Proteomics, informatics, and protein microarrays potentially meet all three of these needs; yet integration is critical for maximizing their potential for success. Complete discovery research is a team effort including basic biological researchers, application researchers, bioinformaticists, database developers, chemists, and engineers (software, material, and microfluidic). This program incorporates each discipline into a comprehensive unit to produce profitable results.

 
 
Organized by: Cambridge Healthtech Institute
Invited Speakers: Dr. Peter J. Boogaard, Applera Corporation
Dr. Jennifer Brockman, HTS Biosystems, Inc.
Dr. Dolores J. Cahill, Max-Planck-Institute of Molecular Genetics
Dr. Hauke Clausen-Schaumann, nanotype GmbH
Dr. Emmanuel Delamarche, IBM Zurich Research Laboratory
Dr. Christoph Eckerskorn, Tecan Munich GmbH
Dr. Sarah Evans, Amersham Biosciences UK Limited
Dr. Mathias Goeschl, LION bioscience AG
Dr. José Luis Pérez Gracia, Eli Lilly & Co., Inc.
Dr. Christoph Hüls, Protagen AG
Dr. Ismail Moarefi, SiREEN AG
Dr. Smita Patel, Merck Sharp & Dohme
Dr. Keith Rose, GeneProt, Inc.
Dr. Arne Skerra, PIERIS Proteolab AG
Dr. Ulf Skoglund, Karolinska Institute and Sidec Technologies AB
Dr. Gill Smith, AstraZeneca R&D Charnwood
Dr. Serhiy Souchelnytskyi, Ludwig Institute for Cancer Research
Dr. Giulio Superti-Furga, Cellzome AG
Dr. Michael Taussig, The Babraham Institute
Dr. Markus Templin, University of Tübingen
Dr. Peter Uetz, Forschungszentrum Karlsruhe
Dr. Mathias Uhlén, Royal Institute of Technology and Affibody AB

 
Deadline for Abstracts: March 21, 2003
 
Registration: Available Online Call:617-630-1300/fax: 617-630-1325 e-mail: chi@healthtech.com
E-mail: eeskedal@healthtech.com
 
  Posted by:   elaine eskedal  
Host: wks152.healthtech.com
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.